Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis

Apoptosis

Volumn 13, Issue 1, 2008, Pages 109-117

  Scheel Toellner, Dagmar ^a   Raza, Karim ^a   Assi, Lakhvir ^a   Pilling, Darrell ^a   Ross, Emma J ^a   Lee, Wing Yiu ^a   Curnow, S John ^a   Buckley, Christopher D ^a   Akbar, Arne N ^b   Lord, Janet M ^a   Salmon, Mike ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Bcl 2; Cytokines; Lymphocytes; Programmed cell death; Survival

Indexed keywords

CASPASE 3; CYCLOHEXIMIDE; CYTOKINE; LEUCINE; PHYTOHEMAGGLUTININ; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 2; TRITIUM;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DEATH; CELL FRACTIONATION; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 38049156387     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0143-z     Document Type: Article

References (50)

1. Duke RC, Cohen JJ (1986) IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 5:289-299
2. Akbar AN, Borthwick NJ, Wickremasinghe RG et al (1996) Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro- apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26:294-299
3. Pilling D, Akbar AN, Girdlestone J et al (1999) Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 29:1041-1050
4. Kuroda K, Yagi J, Imanishi K et al (1996) Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. J Immunol 157:1422-1431
5. Vella AT, Dow S, Potter TA, Kappler J, Marrack P (1998) Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 95:3810-3815
6. Kaneko S, Suzuki N, Koizumi H, Yamamoto S, Sakane T (1997) Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones. Clin Exp Immunol 109:185-193
7. Curnow SJ, Scheel-Toellner D, Jenkinson W et al (2004) Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. J Immunol 173:5290-5297
8. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513-519
9. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312
10. Reed JC (1997) Cytochrome c: can't live with it-can't live without it. Cell 91:559-562
11. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316
12. Strasser A, Pellegrini M (2004) T-lymphocyte death during shutdown of an immune response. Trends Immunol 25:610-615
13. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773-776
14. Chao DT, Korsmeyer SJ (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419
15. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251
16. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
17. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
18. O'Reilly LA, Huang DC, Strasser A (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15:6979-6990
19. Yang J, Liu X, Bhalla K et al (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132
20. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487
21. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656
22. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB (2001) BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15:1481-1486
23. Cheng EH, Wei MC, Weiler S et al (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8:705-711
24. Willis SN, Fletcher JI, Kaufmann T et al (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856-859
25. Zhu Y, Swanson BJ, Wang M et al (2004) Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells. Proc Natl Acad Sci USA 101:7681-7686
26. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626-629
27. Cheng EH, Kirsch DG, Clem RJ et al (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966-1968
28. Kirsch DG, Doseff A, Chau BN et al (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274:21155-21161
29. Mueller DL, Seiffert S, Fang W, Behrens TW (1996) Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells. J Immunol 156:1764-1771
30. Strasser A, Harris AW, Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899
31. Deng G, Podack ER (1993) Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 90:2189-2193
32. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY (1994) Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700-3704
33. Nakayama K, Nakayama K, Negishi I et al (1993) Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261:1584-1588
34. Matsuzaki Y, Nakayama K, Nakayama K et al (1997) Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 89:853-862
35. Broome HE, Dargan CM, Krajewski S, Reed JC (1995) Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 155:2311-2317
36. Broome HE, Dargan CM, Bessent EF, Krajewski S, Reed JC (1995) Apoptosis and Bcl-2 expression in cultured murine splenic T cells. Immunology 84:375-382
37. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714
38. Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res 54:2468-2471
39. Lithgow T, van Driel R, Bertram JF, Strasser A (1994) The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ 5:411-417
40. Motoyama S, Kitamura M, Saito S et al (1998) Bcl-2 is located predominantly in the inner membrane and crista of mitochondria in rat liver. Biochem Biophys Res Commun 249:628-636
41. Petit PX, O'Connor JE, Grunwald D, Brown SC (1990) Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem 194:389-397
42. Akbar AN, Borthwick N, Salmon M et al (1993) The significance of low Bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178:427-438
43. Orteu CH, Poulter LW, Rustin MH, Sabin CA, Salmon M, Akbar AN (1998) The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 161:1619-1629
44. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 189:1815-1822
45. Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S (2000) Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol 20:1886-1896
46. Ibiza S, Victor VM, Bosca I et al (2006) Endothelial nitric oxide synthase regulates T cell receptor signaling at the immunological synapse. Immunity 24:753-765
47. Azad N, Vallyathan V, Wang L et al (2006) S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J Biol Chem 281:34124-34134
48. Vairo G, Innes KM, Adams JM (1996) Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13:1511-1519
49. Hildeman DA, Zhu Y, Mitchell TC et al (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759-767
50. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM (1999) Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 96:14943-14948